Cellink Ab Stock Current Ratio
| CLLKF Stock | USD 2.93 0.08 2.81% |
Cellink AB fundamentals help investors to digest information that contributes to Cellink AB's financial success or failures. It also enables traders to predict the movement of Cellink Pink Sheet. The fundamental analysis module provides a way to measure Cellink AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellink AB pink sheet.
Cellink |
Cellink AB Company Current Ratio Analysis
Cellink AB's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Cellink AB Current Ratio | 2.35 X |
Most of Cellink AB's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellink AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Cellink AB has a Current Ratio of 2.35 times. This is 19.24% lower than that of the Healthcare sector and 30.88% lower than that of the Medical Devices industry. The current ratio for all United States stocks is 8.8% lower than that of the firm.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Cellink Fundamentals
| Return On Equity | 0.0068 | |||
| Return On Asset | -0.025 | |||
| Profit Margin | 0.02 % | |||
| Current Valuation | 973.88 M | |||
| Shares Outstanding | 69.07 M | |||
| Shares Owned By Insiders | 38.50 % | |||
| Shares Owned By Institutions | 26.80 % | |||
| Price To Book | 1.23 X | |||
| Price To Sales | 4.61 X | |||
| Revenue | 1.26 B | |||
| Gross Profit | 1.03 B | |||
| EBITDA | 37.7 M | |||
| Net Income | (227.6 M) | |||
| Total Debt | 1.35 B | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 2.35 X | |||
| Cash Flow From Operations | (409.2 M) | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 1.18 K | |||
| Beta | 2.1 | |||
| Market Capitalization | 657.9 M | |||
| Total Asset | 9.75 B | |||
| Net Asset | 9.75 B |
About Cellink AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellink AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellink AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellink AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cellink Pink Sheet
Cellink AB financial ratios help investors to determine whether Cellink Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cellink with respect to the benefits of owning Cellink AB security.